- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07372183
Wound Healing Following Extraction and Ridge Preservation in Smokers and Non-smokers
January 20, 2026 updated by: Vrisiis Kofina, Marquette University
The goal of this study is to evaluate bone wound healing following extraction and alveolar ridge preservation (bone graft and membrane) clinically, histologically and in relation to gene expression in smokers and non-smokers.
Data from a small group of participants will be analyzed after age-matched subjects undergo extraction and alveolar ridge preservation prior to implant placement.
The data obtained in this pilot study will be used to plan a full-fledged study involving a larger number of smoking and non-smoking participants to compare the two groups.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Detailed Description
All research procedures will start after IRB approval.
Patients of the Graduate Periodontics Clinic in need of extraction, bone graft and membrane will be recruited.
There will be two groups (smokers and non-smokers) and their demographic and social, periodontal, surgery-related, anatomical and healing variables as well as patient-reported outcomes will be recorded at different time points (immediately before, during and immediately after surgery and 1, 2, 6 weeks and 4 months) in order to evaluate wound healing outcomes and differences between the groups.
The demographic and social variables evaluated are age, gender, race, medical history, medications, smoking (via interview and breath test-smokerlyzer) and alcohol consumption (via interview).
The periodontal variables are tooth mobility, probing depth, attachment level, gingival and plaque index.
The surgery-related variables include intraoperative complications, duration of procedure, anesthetic amount, type and approach and operator experience.
The anatomical variables are bone height and width (buccolingual and buccal dimension), bone density (in Cone Beam Computed Tomographies - CBCTs) and gingival width and thickness.
The healing variables include wound opening (tested clinically and in photos), bleeding, grafting material discharge, flap necrosis, loose sutures, and temporary restoration adjustment.
The patient-reported outcomes are Oral Health Impact Questionnaire-14 (OHIP-14), Visual Analogue Scale (VAS) for pain, swelling and difficulty of mouth opening.
At 4 months during the implant placement appointment, a bone core will be harvested via a 3D printed surgical guide based on virtual CBCT planning.
The core willl be used of microCT and histological analysis as well as total RNA extraction and RNA sequencing.
Study Type
Observational
Enrollment (Estimated)
12
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Vrisiis Kofina, DDS, MS
- Phone Number: 516-817-0393
- Email: vrisiis.kofina@marquette.edu
Study Contact Backup
- Name: McKenna Schnack, DDS, MS
- Phone Number: 515-822-3552
- Email: mckenna.schnack@marquette.edu
Study Locations
-
-
Wisconsin
-
Milwaukee, Wisconsin, United States, 53233
- Marquette University School of Dentistry Graduate Periodontics Clinic
-
Contact:
- Vrisiis Kofina, DDS, MS
- Phone Number: 4142886521
- Email: vrisiis.kofina@marquette.edu
-
Contact:
- Arndt Guentsch, DMD, PhD, MHBA, MS
- Phone Number: 4142886089
- Email: arndt.guentsch@marquette.edu
-
Principal Investigator:
- Vrisiis Kofina, DDS, MS
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Sampling Method
Non-Probability Sample
Study Population
Patients scheduled for tooth extraction and alveolar ridge preservation (bone graft and membrane) in the Graduate Periodontics Clinic at Marquette University School of Dentistry.
Description
Inclusion Criteria:
- Adult patients (18-75 years)
- Good general health (controlled conditions)
- Smokers (≥10 cigarettes/day for ≥5 years) and never smokers. Confirmation of smoking status will be done via use of a smokerlyzer. The cut-off point for distinguishing smokers from non-smokers is 8 carbon monoxide parts per million (ppm).
- Periodontal status: periodontal health, gingivitis on intact or reduced periodontium, treated periodontitis
- Intact post-extraction bony walls or less than 50% bone dehiscence
- Distance at least 8 mm of vertical bone height between bone crest and anatomical structures (i.e. sinus floor, inferior alveolar nerve (IAN) canal, mental foramen)
- Extracted tooth root in the same three-dimensional position as the future implant placement so that the bone core biopsy can be taken from a site totally within the confines of the former tooth socket without inclusion of surrounding native alveolar bone
- Scheduled for single tooth extraction with bone graft placement and membrane
Exclusion Criteria:
- Uncontrolled periodontal disease
- Uncontrolled systemic disease
- Pregnancy
- Use of therapy and/or medication that impairs wound healing (e.g., bisphosphonates, steroids, chemotherapy, radiotherapy etc.)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Smokers
Subjects are qualified as smokers if they report smoking ≥10 cigarettes/day for ≥5 years, and maintain a 8ppm carbon monoxide concentration or higher via smokerlyzer test.
|
Observational study; alveolar ridge preservation
|
|
Non-smokers
Subjects qualify as nonsmokers if they have never smoked and upon confirmation by the smokerlyzer test of carbon monoxide concentation of less than 8ppm.
|
Observational study; alveolar ridge preservation
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Clinical Parameters
Time Frame: Measured before surgery, during surgery and at 4 months
|
bone width
|
Measured before surgery, during surgery and at 4 months
|
|
Clinical Parameters
Time Frame: Measured before surgery, during surgery and at 4 months
|
bone height
|
Measured before surgery, during surgery and at 4 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Genetic Parameters
Time Frame: Bone samples harvested at 4 months
|
RNA transcriptomic analysis
|
Bone samples harvested at 4 months
|
|
Histological Parameters
Time Frame: Samples harvested at 4 months
|
Histological analysis of bone cores: %mineralized bone
|
Samples harvested at 4 months
|
|
Histological Parameters
Time Frame: Samples harvested at 4 months
|
Histological analysis of bone cores: %osteoid
|
Samples harvested at 4 months
|
|
Histological Parameters
Time Frame: Samples harvested at 4 months
|
Histological analysis of bone cores: %residual bone graft
|
Samples harvested at 4 months
|
|
Histological Parameters
Time Frame: Samples harvested at 4 months
|
Histological analysis of bone cores: %soft tissue
|
Samples harvested at 4 months
|
|
Histological Parameters
Time Frame: Samples harvested at 4 months
|
Histological analysis of bone cores: numbers of osteoblasts and osteoclasts
|
Samples harvested at 4 months
|
|
Micro-CT Parameters
Time Frame: Samples harvested at 4 months
|
Histological analysis of bone cores: bone mineral density
|
Samples harvested at 4 months
|
|
Micro-CT Parameters
Time Frame: Samples harvested at 4 months
|
Histological analysis of bone cores: tissue mineral density
|
Samples harvested at 4 months
|
|
Micro-CT Parameters
Time Frame: Samples harvested at 4 months
|
Histological analysis of bone cores: bone volume / tissue volume (BV/TV)
|
Samples harvested at 4 months
|
|
Micro-CT Parameters
Time Frame: Samples harvested at 4 months
|
Histological analysis of bone cores: trabecular number
|
Samples harvested at 4 months
|
|
Micro-CT Parameters
Time Frame: Samples harvested at 4 months
|
Histological analysis of bone cores: trabecular separation
|
Samples harvested at 4 months
|
|
Micro-CT Parameters
Time Frame: Samples harvested at 4 months
|
Histological analysis of bone cores: trabecular thickness
|
Samples harvested at 4 months
|
|
Patient-reported Parameters
Time Frame: Measured before surgery, at 1, 2 and 6 weeks, and 4 months
|
Oral Health Impact Profile -14 (OHIP-14).
Range from 0 (no impact) to 56 (most severe impact).
|
Measured before surgery, at 1, 2 and 6 weeks, and 4 months
|
|
Patient-reported Parameters
Time Frame: Measured before surgery and at 1, 2 and 6 weeks, and 4 months
|
VAS for pain (0-100).
Zero indicates no pain and 100 the worst pain imaginable.
|
Measured before surgery and at 1, 2 and 6 weeks, and 4 months
|
|
Patient-reported Parameters
Time Frame: Measured before surgery and at 1, 2 and 6 weeks, and 4 months
|
VAS for swelling (0-100).
Zero indicates no swelling and 100 the worst swelling imaginable.
|
Measured before surgery and at 1, 2 and 6 weeks, and 4 months
|
|
Patient-reported Parameters
Time Frame: Measured before surgery, at 1, 2 and 6 weeks, and 4 months
|
VAS for difficulty of mouth opening (0-100).
Zero indicates no difficulty of mouth opening and 100 complete inability to open mouth.
|
Measured before surgery, at 1, 2 and 6 weeks, and 4 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Clinical Parameters
Time Frame: Measured at baseline (before surgery)
|
gingival width
|
Measured at baseline (before surgery)
|
|
Clinical Parameters
Time Frame: Measured at baseline (before surgery)
|
gingival thickness
|
Measured at baseline (before surgery)
|
|
Clinical Parameters
Time Frame: Measured immediately after surgery, at 1, 2 and 6 weeks and 4 months
|
wound opening
|
Measured immediately after surgery, at 1, 2 and 6 weeks and 4 months
|
|
Clinical Parameters
Time Frame: Measured at 1, 2 and 6 weeks and 4 months
|
bleeding
|
Measured at 1, 2 and 6 weeks and 4 months
|
|
Clinical Parameters
Time Frame: Measured at 1, 2 and 6 weeks and 4 months
|
grafting material discharge
|
Measured at 1, 2 and 6 weeks and 4 months
|
|
Clinical Parameters
Time Frame: Measured at 1, 2 and 6 weeks and 4 months
|
flap necrosis
|
Measured at 1, 2 and 6 weeks and 4 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Vrisiis Kofina, DDS, MS, Marquette University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
January 25, 2026
Primary Completion (Estimated)
October 1, 2028
Study Completion (Estimated)
October 1, 2028
Study Registration Dates
First Submitted
December 2, 2025
First Submitted That Met QC Criteria
January 20, 2026
First Posted (Actual)
January 28, 2026
Study Record Updates
Last Update Posted (Actual)
January 28, 2026
Last Update Submitted That Met QC Criteria
January 20, 2026
Last Verified
January 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- HR-4728
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Wound Healing
-
University of Witten/HerdeckeKCI Europe Holding B.V.CompletedImpaired Wound Healing | Wound Healing Disorder | Abdominal Wound Healing Disorder | Abdominal Wound Healing Impairment | Acute Postsurgical Subcutaneous WoundBelgium, Germany
-
Saglik Bilimleri UniversitesiCompletedWound Healing | Tooth Extraction Site HealingTurkey (Türkiye)
-
Peking University Third HospitalRecruitingWound Heal | Wound Healing DelayedChina
-
Ursula WerraUniversitätsklinikum Hamburg-Eppendorf; neoplas med GmbHNot yet recruitingWound Healing | Prevention | Wound Healing Complication | Peripheral Occlusive Disease | Cold Atmospheric PlasmaGermany
-
First Affiliated Hospital, Sun Yat-Sen UniversityNot yet recruitingWound Healing
-
Linio Biotech OyHospital Nova of Central FinlandActive, not recruiting
-
Brigham and Women's HospitalRecruitingWound Infection and Wound HealingUnited States
-
First Affiliated Hospital, Sun Yat-Sen UniversityNot yet recruitingWound Healing
-
Inonu UniversityCompletedWound HealingTurkey (Türkiye)
-
Pakistan Institute of Medical SciencesNot yet recruitingWound Healing | Wound Infection Post-Traumatic
Clinical Trials on observational study
-
Taysha Gene Therapies, Inc.Withdrawn
-
University of Castilla-La ManchaRecruitingKnee OsteoarthritisSpain
-
University of ManitobaCompletedObesity | Pregnancy | Cesarean SectionCanada
-
Drexel UniversityCompletedOsteoporosisUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI); Merck Sharp & Dohme LLCRecruitingMalignant Solid Neoplasm | Hematopoietic and Lymphatic System NeoplasmUnited States
-
Roswell Park Cancer InstituteRecruitingCigarette Smoking-Related CarcinomaUnited States
-
Children's Oncology GroupNot yet recruitingChildhood Hematopoietic and Lymphatic System Neoplasm | Childhood Malignant Solid Neoplasm
-
Ohio State University Comprehensive Cancer CenterAmerican Association for Cancer ResearchRecruitingAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Breast Carcinoma | Hormone Receptor-Positive Breast CarcinomaUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)RecruitingMalignant Solid Neoplasm | Hematopoietic and Lymphatic System NeoplasmUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)Not yet recruitingEndometrial CarcinomaUnited States